Annual Financial Reporting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10508 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Annual Financial Reporting

posted on Mar 22, 2024 12:55PM

The 2023 audited Financial Statement for RVX should be due at month's end, March 31, 2024.

Anxious to see how much financial support RVX is getting from Zenith to keep the light on.

Zenith's 3rd quarter filings (January 31, 2024) are overdue.

Koo

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply